1.Comparison of the effectiveness of five time series models for prediction ofpulmonary tuberculosis incidence
Yingdan WANG ; Chunjie GAO ; Lei WANG
Journal of Preventive Medicine 2022;34(12):1194-1200
Objective:
To compare the effectiveness of seasonal autoregressive integrated moving average (SARIMA) model, additive Holt-Winters model, Holt-Winters' multiplicative model, GM (1, 1) model and linear combination prediction model for prediction of pulmonary tuberculosis incidence.
Methods:
Data pertaining to monthly incidence of pulmonary tuberculosis in Xinjiang Uyghur Autonomous Region from 2004 to 2008 were captured from Public Health Sciences Data Center. The SARIMA model, additive Holt-Winters model, Holt-Winters' multiplicative model, GM (1, 1) model and linear combination prediction model were created based on the incidence of pulmonary tuberculosis from January 2004 to June 2018, to predict the incidence of pulmonary tuberculosis from July to December 2018. The predictive value of each model was evaluated using absolute percentage error (APE), mean APE (MAPE) and root mean square error (RMSE), and the best model was selected based on minimum APE, MAPE and RMSE.
Results:
The SARIMA model showed the minimum APE (10.94%), 11.01% and 7.96% MAPE and 564 and 419 RMSE at the model-fitting and prediction phases; followed by the linear combination prediction model, with 13.71% APE, 12.01% and 7.94% MAPE and 600 and 447 RMSE at the model-fitting and prediction phases, while the additive Holt-Winters model, Holt-Winters' multiplicative model and GM (1, 1) model showed a low predictive value.
Conclusion
The SARIMA and linear combination prediction models are superior to additive Holt-Winters model, Holt-Winters' multiplicative model and GM (1, 1) model for prediction of pulmonary tuberculosis incidence.
2.Clinical study of continuous veno-venous hemofiltration on the hemodialysis patients with refractory hypertension
Yang YI ; Jianrao LU ; Bo GU ; Hanqing WANG ; Yi XUAN ; Yingdan ZHAO ; Beiye DONG ; Wenying GE
Clinical Medicine of China 2011;27(2):152-155
Objective To study the short-term clinical efficacy and its possible mechanism of refractory hypertension(RH) treated by continuous veno-venous hemofiltration (CVVH) in maintenance hemodialysis (MHD) patients. Methods Thirty-four MHD patients with RH treated with CVVH enrolled in the treatment group,all these patients were treatment of 2 -3 times,each time 8 - 10 hours. Thirty MHD patients with wellcontroled blood pressure were recruited as control. Changes of blood pressure, dry weight, plasma levels of parathyroid hormone (PTH), renin ( RA), angiotensin Ⅰ , Ⅱ ( AT Ⅰ , AT Ⅱ ), aldosterone ( Ald ) were observed before and after hemodialysis. Results In the treatment group,compared with pre-treatment, the blood pressure decreased significantly with an effective rate of 64.7% and efficient rate of 100. 0%. Before treatment, plasma RA was ([1.10 ±0.25] μg/(L · h)and [0:78 ±0.26] μg/(L · h),AT Ⅰ was [0.89 ±0.21] μg/L and [ 0. 52 ± 0. 14 ] μg/L, AT Ⅱ was [ 177.68 ± 89.46 ] ng/L and [ 89. 25 ± 12. 84 ] ng/L, Ald was [72. 06 ± 11.47 ]ng/L and [ 48.92 ± 8. 65 ] ng/L, PTH was [ 306. 81 ± 69. 37 ] ng/L and [ 248.76 ± 134. 62 ] ng/L in the treatment and control group respectively. All the measurements in the treatment group were significantly higher than those in the control group (P < 0. 05 ). In the treatment group, compared to pre-treatment, plasma RA significantly decreased ( [ 1.10 ± 0. 25 ]μg/ ( L · h) vs [ 0. 76 ± 0. 17 ] μg/( L · h ), as well as AT Ⅰ ( [ 0. 89 ±0.21]μg/L vs [0.50 ±0.12] μg/L),ATⅡ([177.68±89.46]ng/L vs [ 87.13±14.22] ng/L),Ald ([72.06±11.47]ng/Lvs [ 46. 01± 9. 86 ] ng/L ) and PTH ( [ 306. 81 ±69.37]ng/L vs [ 186.53 ±32.93 ] ng/L) ( P < 0. 05 ). However, there was no significant changes in the above mentioned measurements between before and after hemodialysis in the control group (P > 0. 05). Conclusion CVVH may be an effective methods in the treatment of MHD patients with RH, and its antihypertensive mechanisms may be that CVVH can effectively remove the excess water in the body, and reduce plasma RA, AT Ⅰ , AT Ⅱ ,Ald and PTH levels.
3.Investigation on the disorders in calcium and phosphorus metabolism and abnormity in parathyroid function in the patients with maintenance hemodialysis
Yang YI ; Jianrao LU ; Bo GU ; Hanqing WANG ; Beiye DONG ; Yi XUAN ; Yingdan ZHAO ; Zhiyong GUO
Clinical Medicine of China 2011;27(11):1123-1126
Objective To investigate disorders in calcium and phosphorus metabolism and abnormity in parathyroid function and their related factors in maintenance hemodialysis(MHD)patients.Methods We collected serum Hb,SCr,BUN,calcium,phosphorus,iPTH,high sensitivity C-reactive protein(hs-CRP),albumin and calculated albumin-corrected Ca and Kt/V from 198 patients with MHD in Jing'an District Central Hospital,Shanghai from Jan.2009 to Dec.2010.The calcium and phosphorus metabolism and parathyroid function were evaluated according to the guidelines of bone metabolism and controlling of bone disease in Kidney Disease Outcome Quality Initiative(KDOQI)recommended by National Kidney Foundation of the United States.198 patients were classified into the standard group(150-300 ng/L),lower than the standard group(<150 ng/L)and higher than the standard group(> 300 ng/L)according to serum iPTH levels.Results In the 198 cases,110 cases were normal in serum Ac-Ca(55.6%); 118 cases were normal in serum phosphorus (59.6%); 143 cases were normal in Ca × P(72.3%); 39 cases were normal in iPTH(19.7%).All four items up to the standard were 28 cases(14.1%)among 198 cases.However,132(66.7%)patients showed lower than 150 ng/L in serum iPTH.The average serum iPTH gradually decreased with age.The senior patients demonstrated the highest average serum Hs-CRP,the lowest average serum phosphorus and the lowest albumin.There were no statistical significance in sex,hemodialysis duration,diabetes,blood pressure,Hb,Bun,SCr,Ac-Ca and Kt/V among three groups.Conclusion The disorders in calcium and phosphorus metabolism and abnormity in parathyroid function is common in the MHD patients.We should pay attention to hypofunction of parathyroid gland in the patients with MHD,which may be related to aging,malnutrition and potential infection.These findings need further investigation.
4.The safe zones of posterior miniscrew implant placement in different sagittal skeletal features
Qiaojing WANG ; 厦门新开元医院口腔科 ; Zhenxian HUANG ; Yingdan PAN ; Liwei XIAO
Journal of Practical Stomatology 2017;33(5):661-664
Objective:To measure the mesio-distal interradicular space of posterior teeth at different height by CBCT.Methods:60 subjects with skeletal Class Ⅰ,Ⅱ and Ⅲ patterns were included(n =20).From the distal of first premolar to the mesial of second molar,the mesiodistal width at the height of 2,4,6,8 and 10 mm from the alveolar crest were measured and analysed.Results:The interradicular distance was larger than 3 mm within 4-10 mm height in maxilla and in mandible.The maxillary mesiodistal width values measured between the first premolar and second premolar in skeletal Class Ⅰ and Class Ⅱ pattern was greater than that in Class Ⅲ(P <0.05) and there was no significant difference in other zones.In the mandible,the values of skeletal Class Ⅲ pattern were greater than those of skeletal Class Ⅰ and Class Ⅱ pattern(P <0.05).Conclusion:The suitable interradicular zone is within 4-8 mm to the alveolar crest between the second premolar and first molar for miniscrew implant placement in maxilla,and over 4 mm between the first molar and second molar in mandible.The difference of interradicular spaces in sagittal skeletal features is existed.